UPCC 65518 Imaging Sex Differences in Smoking-Induced Pulmonary

Recruiting

18 years - 45 years

All

Phase 1

100 participants needed

1 Location

Brief description of study

The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called [18F]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.

- Between 18–45 years old

- Nicotine smoker, and/or cannabis smoker, or non smoker

- Willing to complete one PET/CT scan

There will be a screening visit that includes a urine drug test, physical exam, questionnaires and interviews. Eligible participants will undergo a PET/CT scan session. All participants will be compensated for their participation.

This study does not provide treatment.

Detailed description of study

This study will see how the tracer is taken up in the lungs using an imaging scan called Positron Emission Tomography / Computed Tomography (PET/CT). [18F]NOS is an experimental radioactive molecule used in PET imaging to measure inflammation in various organs in the body. Investigators are interested in studying whether there are differences in lung inflammation between E-cigarette users (vapers) cigarette smokers and non-smokers. [18F]NOS has not yet been approved by the Food and Drug Administration (FDA) for use except in a research study. The use of [18F]NOS in this study is allowed under an Investigational New Drug Application approved by the FDA.

Investigators are also going to be studying how the information from the PET/CT scan compares to other markers of inflammation in the blood. During the PET scan, Investigators will image Brain and Lungs in order to see if there is a difference between inflammation seen in the brain and the lungs and if these differences change depending on whether a subject is a smoker, e-cigarette user or non-smoker.

Consented participant in this study will undergo one (1) experimental [18F]NOS PET/CT scan. During the scan, PET/CT images will be taken of participant chest/torso in order to capture their lungs and a short image will be taken of their brain. Blood samples will be taken at various time points to test for markers of inflammation and to measure the concentration of the tracer in participants blood during the scan and participants will undergo some specific psychological questionnaires and tasks.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Smoking, Cigarette, Smoking E-cigarette, Healthy Volunteer, Cannabis use,
Age: 18 years - 45 years
Gender: All

Inclusion Criteria:

Participants will be 18-45 years of age
Subject must meet one of the following criteria:
NIC vapers: current e-cigarette use of nicotine at least 5 days per week for the past year, no current combustible cigarette use, cannabis vaping, or cannabis smoking during the 30 days prior to study enrollment
CAN vapers: current e-cigarette use of cannabis at least 5 days per week for the past year, no current combustible cigarette use, cannabis smoking, or nicotine vaping during the 30 days prior to study enrollment
Cigarette smokers: current cigarette smoking of at least 5 cigarettes per day, 4 days per week for the past year with no e-cigarette use (cannabis or nicotine) during the 30 days prior to study enrollment
Dual combustible and e-cigarette users: current e-cigarette use of cannabis and/or nicotine at least 5 days per week for the past year with cigarette or cannabis smoking during the 30 day prior to study enrollment
Poly-use nicotine and cannabis group: current e-cigarette use of nicotine and/or cigarette use (5 cigarettes per day) and/or use of cannabis, at least 4 days per week during the 30 days prior to study enrollment.
Non-Smokers: reported non-smoking history or < 100 lifetime cigarettes, < 100 e-cigarette use episodes, and < 100 lifetime cannabis use episodes, and no smoking in the past 30 days.
Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.

Exclusion Criteria:

Females who are pregnant or breast feeding at the time of screening will not be eligible for this study; a urine pregnancy test will be performed in women of child-bearing potential at screening and at the PET/CT scan visit.
Current untreated and unstable diagnosis of substance use disorder, except nicotine or cannabis use disorder
Positive urine drug screen for opiates, methamphetamine or cocaine at screening
Current unstable and/or untreated major depression or psychotic disorder per medical record review or self-reported
Use of inhaled or oral corticosteroids or anti-inflammatory medications per medical record review or self-report
History of lung trauma
Active (or within the previous 4 weeks of screening) lung infection or lung disease that impact uptake of [¹⁸F]NOS (e.g. tuberculosis, cystic fibrosis)
Inability to tolerate imaging procedures in the opinion of an investigator or treating physician
Any current or past medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study

Updated on 22 Apr 2026. Study ID: 18-0509

Pre-Screener

Check if you are eligible Enter contact details Select a study center Select best time to contact

Are you between the ages of 18-45?

Yes No

Preview complete

The prescreener preview is complete. You may now close the preview.

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center